Skip to main content
Log in

Japan ramps up patent effort to keep iPS lead

  • News
  • Published:

From Nature

View current issue Submit your manuscript

United States in race to commercialize pluripotent stem cells.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

References

  1. Takahashi, K. et al. Cell 131, 861–872 (2007).

    Article  Google Scholar 

  2. Yu, J. et al. Science 318, 1917–1920 (2007).

    Article  Google Scholar 

  3. Masaki, H. et al. Stem Cell Res. 1, 105–115 (2007).

    Google Scholar 

Download references

Authors

Additional information

See also Correspondence: Japan should intensify embryonic stem-cell investigations

Related links

Related links

Related links in Nature Research

Nature Reports Stem Cells

Rights and permissions

Reprints and permissions

About this article

Cite this article

Cyranoski, D. Japan ramps up patent effort to keep iPS lead. Nature 453, 962–963 (2008). https://doi.org/10.1038/453962a

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/453962a

  • Springer Nature Limited

This article is cited by

Navigation